(Q64151508)
Statements
A Phase 3, Placebo-controlled, Double-blind Comparative Study of KHK4827 With an Open-label Extension Period in Subjects With Systemic Sclerosis Who Have Moderate to Severe Skin Thickening (English)
0 references
May 2019
0 references
1 April 2021
0 references
100
0 references
18 year
0 references
70 year
0 references